A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Clinical trial NCT04683679 · RECRUITING

Trial details

NCT number: NCT04683679
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer TNBC - Triple-Negative Breast Cancer Breast Cancer Metastatic Breast Cancer

Start date: 2021-04-21
Primary completion: 2027-01-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.